Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6094]

Risk of secondary cancers after CAR-T cell therapy low, according to large study

Risk of secondary cancers after CAR-T cell therapy low, according to large study

Boosting CAR-T cell therapies from under the skin

Boosting CAR-T cell therapies from under the skin

Healing by proxy: newly discovered drug may treat cancer and inflammation through indirect action

Healing by proxy: newly discovered drug may treat cancer and inflammation through indirect action

FDA approves imetelstat for low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia

FDA approves imetelstat for low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia

ASCO 2024: Innovative combination therapy shows promise for bladder cancer patients unresponsive to standard treatment

ASCO 2024: Innovative combination therapy shows promise for bladder cancer patients unresponsive to standard...

New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells

New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells

Getting personal: Accelerating personalised and precision medicine integration into clinical cancer

Getting personal: Accelerating personalised and precision medicine integration into clinical cancer

Researchers identify key differences in inner workings of immune cells

Researchers identify key differences in inner workings of immune cells

World-first study into precision medicine for high-risk childhood cancer yields extraordinary results

World-first study into precision medicine for high-risk childhood cancer yields extraordinary results

Study finds that a common virus can trigger quicker growth of nasopharyngeal cancer

Study finds that a common virus can trigger quicker growth of nasopharyngeal cancer

More from ecancer